Get the Stockscreener App
1.852
4.63%
0.082
Pre-market:
1.79
-0.062
-3.35%
Autonomix Medical Inc stock is traded at $1.852, with a volume of 24,897.
It is up +4.63% in the last 24 hours and down -6.95% over the past month.
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
See More
Previous Close:
$1.77
Open:
$1.76
24h Volume:
24,897
Relative Volume:
0.21
Market Cap:
$4.02M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+12.93%
1M Performance:
-6.95%
6M Performance:
-83.90%
1Y Performance:
-96.75%
1-Day Range:
$1.755
$1.8799
1-Week Range:
$1.60
$1.8799
52-Week Range:
$1.52
$75.80
Autonomix Medical Inc Stock (AMIX) Company Profile
Name
Autonomix Medical Inc
Sector
Industry
Phone
832-277-7816
Address
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Compare AMIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
1.852 | 4.02M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Autonomix Medical Inc Stock (AMIX) Latest News
Autonomix Medical announces inducement grant - Medical Buyer
Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Autonomix Medical Expands Team with Strategic 5,000-Share Stock Option Grant to New Key Employee - Stock Titan
Autonomix Medical secures new European patent for nerve tech By Investing.com - Investing.com South Africa
Autonomix Medical Granted European Patent For Catheter-Based Neuromodulation Technology - Nasdaq
Autonomix Medical Gains European Patent for Catheter-Based Tech - Medical Product Outsourcing
Autonomix Medical secures new European patent for nerve tech - Investing.com
Autonomix Medical Granted New European Patent For Proprietary Catheter-Based Technology - marketscreener.com
Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology - GlobeNewswire
Autonomix stock plunges to 52-week low of $1.52 amid steep annual decline - Investing.com Australia
Autonomix stock plunges to 52-week low of $1.52 amid steep annual decline By Investing.com - Investing.com South Africa
Analyzing Globus Medical (NYSE:GMED) & Autonomix Medical (NASDAQ:AMIX) - Defense World
Autonomix to begin U.S. clinical studies for FDA approval By Investing.com - Investing.com South Africa
Autonomix to begin U.S. clinical studies for FDA approval - Investing.com
Autonomix Medical, Inc. Engages Leading Medical Experts to - GlobeNewswire
Top Medical Experts Join Forces to Advance Revolutionary Pancreatic Cancer Pain Treatment - Stock Titan
Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO) - GlobeNewswire
Revolutionary Pancreatic Cancer Pain Treatment: Autonomix Medical Reveals First Clinical Results at ECIO 2025 - Stock Titan
Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Update - Defense World
Patent Granted to Autonomix Medical for Sensing Data Collection - Medical Product Outsourcing
Autonomix stock plunges to 52-week low of $1.81 amid market challenges By Investing.com - Investing.com South Africa
Autonomix stock plunges to 52-week low of $1.81 amid market challenges - Investing.com Australia
Financial Analysis: INVO Bioscience (NASDAQ:INVO) & Autonomix Medical (NASDAQ:AMIX) - Defense World
Autonomix Medical announces inducement grant under Nasdaq listing rule 5635(C)(4) - Marketscreener.com
Autonomix Medical Awards Strategic Stock Options Package Under Nasdaq Rules - StockTitan
Can Autonomix Sensing And RF Ablation System Prove Its Mettle In Managing Pancreatic Cancer Pain? - RTTNews
Autonomix Medical Granted US Patent for Catheter-Based Technology; Shares Up 10% Pre-Bell - Marketscreener.com
Autonomix Medical Expands Patent Portfolio with New Issuance for Innovative Sensing and Ablation Technology - Nasdaq
Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology - The Manila Times
Autonomix Medical, Inc. Granted U.S. Patent Covering - GlobeNewswire
Groundbreaking Patent: Autonomix Medical's New Tech 3000x More Sensitive Than Current Solutions - StockTitan
Head to Head Analysis: Autonomix Medical (NASDAQ:AMIX) versus SI-BONE (NASDAQ:SIBN) - Defense World
Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Decline in Short Interest - Defense World
Autonomix Medical finalizes ASIC microchip design - MSN
Autonomix advances pancreatic cancer treatment system - Investing.com Australia
Autonomix Medical Advances Toward US Clinical Trials In 2025 With Apex 6 Generator Integration - Nasdaq
Autonomix advances toward U.S. clinical trials in 2025 - TipRanks
Autonomix advances pancreatic cancer treatment system By Investing.com - Investing.com South Africa
Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation - The Manila Times
Autonomix Medical Achieves Design Lock for Apex 6 Radiofrequency Generator, Advances Towards U.S. Clinical Trials for Pancreatic Cancer Pain Treatment - Nasdaq
Autonomix Medical, Inc. Advances Toward U.S. Clinical - GlobeNewswire
Autonomix Achieves Critical Milestone: FDA-Cleared Technology Powers New Cancer Pain Treatment System - StockTitan
Autonomix stock plunges to 52-week low of $2.23 amid market challenges - Investing.com Australia
Autonomix stock plunges to 52-week low of $2.23 amid market challenges By Investing.com - Investing.com South Africa
Autonomix Medical (NASDAQ:AMIX) versus Adagio Medical (NASDAQ:ADGM) Head-To-Head Review - Defense World
Autonomix Medical, Inc. Announces Abstract Highlighting Technology And Early Proof-Of-Concept Study Results Accepted At The Society Of Interventional Radiology (SIR) Annual Scientific Meeting - MENAFN.COM
Autonomix Medical, Inc. Announces Abstract Highlighting Technology and Early Proof-of-Concept Study Results Accepted at the Society of Interventional Radiology (SIR) Annual Scientific Meeting - GlobeNewswire
Autonomix Medical Inc Stock (AMIX) Financials Data
There is no financial data for Autonomix Medical Inc (AMIX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.01%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):